Bioventus (BVS) Restructuring Costs (2020 - 2026)

Bioventus (BVS) has 6 years of Restructuring Costs data on file, last reported at $454000.0 in Q1 2026.

• For the quarter ending Q1 2026, Restructuring Costs changed N/A year-over-year to $454000.0; the trailing twelve-month figure through Mar 2026 stood at $402000.0 (up 873.08% YoY), and the FY2025 full-year result was $2.2 million, up 4398.08% from the prior year.
• Restructuring Costs for Q1 2026 stood at $454000.0, up from -$52000.0 in the prior quarter.
• Across five years, Restructuring Costs topped out at $4.6 million in Q4 2022 and bottomed at -$71000.0 in Q4 2023.
• The 4-year median for Restructuring Costs is $514500.0 (2022), against an average of $802100.0.
• The widest annual swing landed in 2022, when Restructuring Costs surged 570.54%; it then slumped 104.52% in 2023.
• A 4-year view of Restructuring Costs shows it stood at $4.6 million in 2022, then sank by 101.54% to -$71000.0 in 2023, then advanced by 26.76% to -$52000.0 in 2024, then jumped by 973.08% to $454000.0 in 2026.
• The last three Restructuring Costs figures came in at $454000.0 (Q1 2026), -$52000.0 (Q4 2024), and -$71000.0 (Q4 2023), per Business Quant data.

Peer Comparison